Process flavours with low acrylamide
US-2016249649-A1 · Sep 1, 2016 · US
US9545119B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9545119-B2 |
| Application number | US-201214114189-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 24, 2012 |
| Priority date | Apr 29, 2011 |
| Publication date | Jan 17, 2017 |
| Grant date | Jan 17, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to the use of specific compounds from the structural class of vanillyl lignans or the salts and/or mixtures thereof for modifying or masking unpleasant taste impressions, in particular bitter, astringent, and/or metallic taste impressions. The invention also relates to a corresponding method for masking unpleasant taste impressions, in particular bitter, astringent, and/or metallic taste impressions. The invention further relates to specific preparations containing an effective amount of vanillyl lignans or the salts and/or mixtures thereof to be used in accordance with the invention.
Opening claim text (preview).
The invention claimed is: 1. A method for masking a bitter, an astringent, and/or a metallic taste of caffeine, theobromine, naringin, quinine hydrochloride dihydrate and/or salicin comprising combining the caffeine, theobromine, naringin, quinine hydrochloride dihydrate and/or salicin with one or more vanillyl lignans selected from the group consisting of: (1-(−)) (−)-Matairesinol ((3R,4R)-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl[oxolan-2-one); (2-(−)) (−)-7-hydroxymatairesinol ((3R,4R)-4-[(S)-hydroxy-(4-hydroxy-3-methoxy-phenyl)methyl]-3-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one); (3-(+)) (+)-lariciresinol (4-[[(3R,4R,5S)-5-(4-hydroxy-3-methoxyphenyl)-4-(hydroxy-methyl)-oxolan-3-yl]methyl]-2-methoxyphenol); (4-(−)) (−)-arctigenin ((3R,4R)-4-[(3,4-dimethoxyphenyl)methyl]-3-[(4-hydroxy-3-methoxy-phenyl)m-ethyl[oxolan-2-one); (5-(+)) (+)-isolariciresinol (1,2,3,4-tetrahydro-7-hydroxy-1-(4-hydroxy-3-methoxy-phenyl)-6-methoxy-2,-3-naphthalenedimethanol); (6-(−)) (−)-.alpha.-conidendrin ((3aR,9R,9aS)-7-hydroxy-9-(4-hydroxy-3-methoxyphenyl)-6-methoxy-3a,4,9,9a-tetrahydro-1H-benzo[f][2]benzofuran-3-one); (7-(−)) (−)-nortrachelogenin ((3S,4S)-3-hydroxy-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-oxolan-2-on-e); and (8-(+)) (+)-pinoresinol (4-[(3S,3aR,6S,6aR)-6-(4-hydroxy-3-methoxyphenyl)-1,3,3a,4,6,6a-hexahydro-furo[3,4-c]furan-3-yl]-2-methoxyphenol), wherein the stereoisomer purity is greater than 50% relative to all the stereoisomers of the respective vanillyl lignin(s). 2. The method of claim 1 , wherein the stereoisomer purity is greater than 80% relative to all the stereoisomers of the respective vanillyl lignin(s). 3. The method of claim 1 , wherein the total quantity of vanillyl lignans is in the range of 10 mg/kg to less than 300 mg/kg. 4. The method of claim 1 , wherein the total quantity of vanillyl lignans is in the range of 12 mg/kg to 100 mg/kg. 5. The method of claim 1 for masking a bitter, an astringent, and/or a metallic taste of caffeine. 6. The method of claim 1 for masking a bitter, an astringent, and/or a metallic taste of theobromine. 7. The method of claim 1 for masking a bitter, an astringent, and/or a metallic taste of naringin. 8. The method of claim 1 for masking a bitter, an astringent, and/or metallic taste of quinine hydrochloride dehydrate. 9. The method of claim 1 for masking a bitter, an astringent, and/or metallic taste of salicin. 10. A preparation comprising caffeine, theobromine, naringin, quinine hydrochloride dihydrate and/or salicin and one or more vanillyl lignans selected from the group consisting of: (1-(−)) (−)-Matairesinol ((3R,4R)-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one); (2-(−)) (−)-7-hydroxymatairesinol ((3R,4R)-4-[(S)-hydroxy-(4-hydroxy-3-methoxy-phenyl)methyl]-3-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one); (3-(+)) (+)-lariciresinol (4-[[(3R,4R,5S)-5-(4-hydroxy-3-methoxyphenyl)-4-(hydroxy-methyl)-oxolan-3-yl]methyl]-2-methoxyphenol); (4-(−)) (−)-arctigenin ((3R,4R)-4-[(3,4-dimethoxyphenyl)methyl]-3-[(4-hydroxy-3-methoxy-phenyl)m-ethyl[oxolan-2-one); (5-(+)) (+)-isolariciresinol (1,2,3,4-tetrahydro-7-hydroxy-1-(4-hydroxy-3-methoxy-phenyl)-6-methoxy-2,-3-naphthalenedimethanol); (6-(−)) (−)-.alpha.-conidendrin ((3aR,9R,9aS)-7-hydroxy-9-(4-hydroxy-3-methoxyphenyl)-6-methoxy-3a,4,9,9a-tetrahydro-1H-benzo[f][2]benzofuran-3-one); (7-(−)) (−)-nortrachelogenin ((3S,4S)-3-hydroxy-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-oxolan-2-on-e); and (8-(+)) (+)-pinoresinol (4-[(3S,3aR,6S,6aR)-6-(4-hydroxy-3-methoxyphenyl)-1,3,3a,4,6,6a-hexahydro-furo[3,4-c]furan-3-yl]-2-methoxyphenol), wherein the stereoisomer purity is greater than 50% relative to all the stereoisomers of the respective vanillyl lignin(s). 11. The preparation of claim 10 , wherein the stereoisomer purity is greater than 80% relative to all the stereoisomers of the respective vanillyl lignin(s). 12. The preparation of claim 10 , wherein the total quantity of vanillyl lignans is in the range of 10 mg/kg to less than 300 mg/kg. 13. The preparation of claim 10 , wherein the total quantity of vanillyl lignans is in the range of 12 mg/kg to 100 mg/kg. 14. The preparation of claim 10 comprising caffeine. 15. The preparation of claim 10 comprising theobromine. 16. The preparation of claim 10 comprising naringin. 17. The preparation of claim 10 comprising quinine hydrochloride dehydrate. 18. The preparation of claim 10 comprising salicin. 19. The preparation of claim 10 comprising: at least 0.05% by weight of caffeine; at least 0.05% by weight of theobromine; or at least 0.05% by weight of naringin. 20. The preparation of claim 10 comprising: 1% to 2.5% by weight of caffeine; 1% to 2.5% by weight of theobromine; or 0.2% to 2% by weight of naringin.
Natural spices, flavouring agents or condiments; Extracts thereof · CPC title
Flavour masking or reducing agents · CPC title
Addition of bitterness inhibitors · CPC title
Human Necessities · mapped topic
Related publications grouped by family.
Answers are generated from the same data shown on this page.